Group of action: Agents affecting the nervous system

Active ingredient: Cinnarizine

Dosage form: Tablets

Pharmacotherapeutic group: Agents, used for vestibular disorders.

ATC code: N07CA02



Pharmacotherapeutic group   Agents, used for vestibular disorders.

Disorders of cerebral circulation:

  • symptomatic treatment of cerebrovascular disorders including vertigo, ringing in the ears (tinnitus), headache vascular origin, irritability, memory loss and inability to concentrate;
  • migraine prophylaxis.

Peripheral circulatory disorders:

  • Symptomatic treatment of peripheral vascular disorders including Raynaud's disease, akrocyanosis, intermittent claudication, trophic disorders, trophic and varicose ulcers, paresthesia, nocturnal cramps in the limbs, cold limbs.

Balance disorders:

  • symptomatic treatment of labyrinth disorders including vertigo, tinnitus, nystagmus, nausea and vomiting.

Motion Sickness:

  • Prevention of motion sickness
Contraindications   Hypersensitivity to the active substance or to any of the excipients of the drug.
Basic physical and chemical properties   Tablets of white or almost white color.
Shelf life   5 years
Storage conditions   Keep out of reach of children in the original packaging at a temperature not exceeding 25 ° C.